×
Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia PDF
$ 40.00
Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia PDF quantity
$ 40.00
×
Comparative Risk of Seizure With Use of First- and Second-Generation Antipsychotics in Patients With Schizophrenia and Mood Disorders PDF
$ 40.00
Comparative Risk of Seizure With Use of First- and Second-Generation Antipsychotics in Patients With Schizophrenia and Mood Disorders PDF quantity
$ 40.00
×
Rapid Titration of Mood Stabilizers Predicts Remission From Mixed or Pure Mania in Bipolar Patients PDF
$ 40.00
Rapid Titration of Mood Stabilizers Predicts Remission From Mixed or Pure Mania in Bipolar Patients PDF quantity
$ 40.00
×
Factors Associated With COVID-19 Vaccination Uptake Among Community-Dwelling Patients With Severe Mental Illness: A Cross-Sectional Study PDF
$ 40.00
Factors Associated With COVID-19 Vaccination Uptake Among Community-Dwelling Patients With Severe Mental Illness: A Cross-Sectional Study PDF quantity
$ 40.00
×
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF
$ 40.00
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart